Introduction: Transforming growth factor beta (TGF beta) plays a central role in morphogenesis, growth, and cell differentiation. This cytokine is particularly important in cartilage where it regulates cell proliferation and extracellular matrix synthesis. While the action of TGF beta on chondrocyte metabolism has been extensively catalogued, the modulation of specific genes that function as mediators of TGF beta signalling is poorly defined. In the current study, elements of the Smad component of the TGF beta intracellular signalling system and TGF beta receptors were characterised in human chondrocytes upon TGF beta 1 treatment. Methods: Human articular chondrocytes were incubated with TGF beta 1. Then, mRNA and protein levels of TGF beta receptors and Smads were analysed by RT-PCR and western blot analysis. The role of specific protein 1 (Sp1) was investigated by gain and loss of function (inhibitor, siRNA, expression vector). Results: We showed that TGF beta 1 regulates mRNA levels of its own receptors, and of Smad3 and Smad7. It modulates TGF beta receptors post-transcriptionally by affecting their mRNA stability, but does not change the Smad-3 and Smad-7 mRNA half-life span, suggesting a potential transcriptional effect on these genes. Moreover, the transcriptional factor Sp1, which is downregulated by TGF beta 1, is involved in the repression of both TGF beta receptors but not in the modulation of Smad3 and Smad7. Interestingly, Sp1 ectopic expression permitted also to maintain a similar expression pattern to early response to TGF beta at 24 hours of treatment. It restored the induction of Sox9 and COL2A1 and blocked the late response (repression of aggrecan, induction of COL1A1 and COL10A1). Conclusions: These data help to better understand the negative feedback loop in the TGF beta signalling system, and enlighten an interesting role of Sp1 to regulate TGF beta response.